AN2 Therapeutics, Inc. (ANTX) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q1'21 |
|---|
| Total Current Assets | 87.49M | 59.94M | 64.02M | 67.52M | 69.56M | 86.26M | 97.69M | 107.44M | 116.31M | 110.51M | 126.41M | 98.21M | 90.32M | 98.62M | 107.3M | 116.88M | 119.78M | 60.11M | 4.07M |
| Cash & Short-Term Investments | 85.29M | 58M | 61.92M | 62.92M | 67.06M | 83.62M | 93.43M | 104.54M | 114.21M | 107.3M | 123.82M | 95.26M | 88.52M | 96.06M | 104.38M | 113.39M | 118.35M | 58.55M | 4.07M |
| Cash Only | 53.49M | 19.94M | 18M | 18.22M | 19.98M | 21.35M | 33.5M | 26.77M | 24.69M | 15.65M | 32.62M | 40.81M | 26.71M | 27.22M | 28.8M | 40.62M | 82.52M | 12.1M | -4.07M |
| Short-Term Investments | 31.8M | 38.06M | 43.92M | 44.7M | 47.08M | 62.27M | 59.92M | 77.77M | 89.52M | 91.65M | 91.2M | 54.45M | 61.81M | 68.84M | 75.58M | 72.77M | 35.84M | 46.46M | 8.14M |
| Accounts Receivable | 0 | 900K | 400K | 2.7M | 0 | 300K | 1M | 300K | 0 | 1.4M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 2.2M | 1.04M | 1.7M | 1.91M | 300K | 2.34M | 3.26M | 2.6M | 0 | 0 | 2.59M | 13K | 34K | 2.56M | 73K | 13K | 32K | 0 | 0 |
| Total Non-Current Assets | 0 | 2.01M | 3.22M | 8.3M | 11.78M | 5.83M | 0 | 1.04M | 4.95M | 28.24M | 27.4M | 720K | 768K | 3.94M | 2.71M | 3.14M | 720K | 5.21M | -4.07M |
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 53K | 0 | 0 | 0 | 0 | 0 |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 2.01M | 3.22M | 8.3M | 11.48M | 5.02M | 0 | 0 | 3.9M | 27.19M | 26.36M | 0 | 0 | 3.22M | 1.99M | 2.42M | 0 | 3.49M | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 304K | 804K | 0 | 1.04M | 1.04M | 1.04M | 1.04M | 720K | 768K | 667K | 720K | 720K | 720K | 1.72M | -4.07M |
| Total Assets | 87.49M | 61.95M | 67.23M | 75.83M | 81.34M | 92.09M | 97.69M | 108.48M | 121.26M | 138.74M | 153.81M | 98.93M | 91.08M | 102.56M | 110.01M | 120.02M | 120.5M | 65.32M | 0 |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 7.56% | -32.73% | -31.17% | -30.1% | -32.92% | -33.63% | -36.49% | 9.66% | 33.13% | 35.28% | 39.82% | -17.57% | -24.41% | 57.02% | - | - | - | - | - |
| Total Current Liabilities | 5.56M | 8.72M | 2.23M | 2.11M | 8.01M | 10.24M | 10.02M | 10.13M | 10.66M | 14.04M | 14.84M | 11.16M | 8.57M | 7.19M | 4.43M | 4.15M | 5.09M | 3.4M | 0 |
| Accounts Payable | 2.62M | 3.02M | 2.23M | 2.11M | 3.07M | 3.32M | 1.71M | 1.89M | 2.43M | 2.68M | 4.88M | 3.13M | 3.54M | 2.12M | 1.44M | 1.61M | 2.61M | 1.06M | 0 |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 2.95M | 5.7M | 0 | -1.2M | 369K | 2.47M | 3.38M | 6.4M | 321K | 668K | 976K | 195K | 53K | 6K | 8K | 19K | 1.16M | 330K | 0 |
| Current Ratio | 15.73x | 6.87x | 28.76x | 31.96x | 8.68x | 8.43x | 9.75x | 10.61x | 10.91x | 7.87x | 8.52x | 8.80x | 10.54x | 13.72x | 24.21x | 28.17x | 23.55x | 17.70x | - |
| Quick Ratio | 15.73x | 6.87x | 28.76x | 31.96x | 8.68x | 8.43x | 9.75x | 10.61x | 10.91x | 7.87x | 8.52x | 8.80x | 10.54x | 13.72x | 24.21x | 28.17x | 23.55x | 17.70x | - |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 170K | 170K | 4.63M | 4.87M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1K | 1K | 2K | 3K | 4K | 6K | 13K | 0 |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 170K | 170K | 4.63M | 4.87M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1K | 1K | 2K | 3K | 4K | 6K | 13K | 0 |
| Total Liabilities | 5.73M | 8.89M | 6.86M | 6.98M | 8.01M | 10.24M | 10.02M | 10.13M | 10.66M | 14.04M | 14.84M | 11.16M | 8.57M | 7.19M | 4.43M | 4.15M | 5.09M | 3.41M | 0 |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13K | 34K | 53K | 73K | 13K | 32K | 0 | 0 |
| Net Debt | -53.49M | -19.94M | -18M | -18.22M | -19.98M | -21.35M | -33.5M | -26.77M | -24.69M | -15.65M | -32.62M | -40.8M | -26.68M | -27.17M | -28.73M | -40.6M | -82.49M | -12.1M | 4.07M |
| Debt / Equity | - | - | - | - | - | - | - | - | - | - | - | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | -2372.33x | - | -2.81x | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 81.76M | 53.06M | 60.38M | 68.84M | 73.33M | 81.85M | 87.67M | 98.35M | 110.6M | 124.7M | 138.97M | 87.76M | 82.52M | 95.37M | 105.57M | 115.86M | 115.41M | 61.91M | 2.75M |
| Equity Growth % | 11.5% | -35.17% | -31.13% | -30.01% | -33.7% | -34.36% | -36.91% | 12.07% | 34.03% | 30.75% | 31.63% | -24.25% | -28.5% | 54.05% | - | - | 4095.2% | - | - |
| Book Value per Share | 2.40 | 1.76 | 1.99 | 2.28 | 2.44 | 2.74 | 2.94 | 3.30 | 3.72 | 4.19 | 5.42 | 4.50 | 4.26 | 4.92 | 5.46 | 6.02 | 6.07 | 3.41 | 0.20 |
| Total Shareholders' Equity | 81.76M | 53.06M | 60.38M | 68.84M | 73.33M | 81.85M | 87.67M | 98.35M | 110.6M | 124.7M | 138.97M | 87.76M | 82.52M | 95.37M | 105.57M | 115.86M | 115.41M | 61.91M | 2.75M |
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | -250.98M | -240.95M | -232.24M | -222.89M | -216.43M | -205.78M | -198.25M | -185.51M | -171.07M | -154.46M | -137.56M | -120.85M | -105.05M | -89.72M | -77.88M | -66.54M | -56.42M | -47.38M | 0 |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -5K | 57K | 64K | 25K | 48K | 31K | 112K | -27K | 53K | 275K | -122K | -119K | -175K | -374K | -541K | -360K | -158K | -27K | -20.32M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |